These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38145311)

  • 1. Cystatin C and eGFR
    Niu J; Yu J; Huang H; Shi J; Zheng D; Qiu J
    Scand J Clin Lab Invest; 2023 Dec; 83(8):599-603. PubMed ID: 38145311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An arterial spin labeling-based radiomics signature and machine learning for the prediction and detection of various stages of kidney damage due to diabetes.
    Ma F; Shao X; Zhang Y; Li J; Li Q; Sun H; Wang T; Liu H; Zhao F; Chen L; Chen J; Zhou S; Ji Q; Yu P
    Front Endocrinol (Lausanne); 2024; 15():1333881. PubMed ID: 39624821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Accuracy of Standard Equations to Predict Glomerular Filtration Rate for Persons with Spinal Cord Injury: Which Is the "Best Fit?".
    Brown N; Struck K; Romo T; Koek W; Everett Garcia A; Fredrickson M; Trbovich M
    Top Spinal Cord Inj Rehabil; 2024; 30(4):57-65. PubMed ID: 39619822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Dickkopf-3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart Failure.
    Pieper D; Sandek A; Schäfer AK; Dihazi H; Dihazi GH; Leha A; Zeisberg M; Lüders S; Koziolek M; Wallbach M
    J Am Heart Assoc; 2024 Dec; 13(23):e036637. PubMed ID: 39604022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults.
    Inker LA; Tighiouart H; Adingwupu OM; Shlipak MG; Doria A; Estrella MM; Froissart M; Gudnason V; Grubb A; Kalil R; Mauer M; Rossing P; Seegmiller J; Coresh J; Levey AS
    J Am Soc Nephrol; 2023 Dec; 34(12):1953-1964. PubMed ID: 37796982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of race-neutral eGFR equations in patients with decompensated cirrhosis.
    Fallahzadeh MA; Allegretti AS; Nadim MK; Mahmud N; Patidar KR; Cullaro G; Saracino G; Asrani SK
    Liver Transpl; 2024 May; ():. PubMed ID: 38814160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prevalence and associated factors of chronic kidney disease diagnosed by serum creatinine or cystatin C among young people living with HIV in Uganda.
    Nasuuna EM; Tomlinson LA; Kalyesubula R; Dziva Chikwari C; Castelnuovo B; Manabe YC; Nakanjako D; Weiss HA
    BMC Nephrol; 2024 Nov; 25(1):422. PubMed ID: 39587464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant.
    Langer P; John L; Monsef I; Scheid C; Piechotta V; Skoetz N
    Cochrane Database Syst Rev; 2024 May; 5(5):CD013595. PubMed ID: 38695605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants for adults with chronic kidney disease.
    Colombijn JM; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RW
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD008176. PubMed ID: 37916745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes.
    Petrucci MT; Bringhen S; Entrala Cerezo C; Mendes J; Armeni P
    Hematology; 2024 Dec; 29(1):2432815. PubMed ID: 39611731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis.
    Cullaro G; Allegretti AS; Patidar KR; Verna EC; Lai JC
    Liver Transpl; 2025 Jan; 31(1):24-31. PubMed ID: 39041923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Efficacy of an AI-Based Health Coaching Mobile App in Slowing the Progression of Nondialysis-Dependent Chronic Kidney Disease: Retrospective Cohort Study.
    Ma J; Wang J; Ying J; Xie S; Su Q; Zhou T; Han F; Xu J; Zhu S; Yuan C; Huang Z; Xu J; Chen X; Bian X
    J Med Internet Res; 2024 Nov; 26():e54206. PubMed ID: 39402012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
    Davenport C; Arevalo-Rodriguez I; Mateos-Haro M; Berhane S; Dinnes J; Spijker R; Buitrago-Garcia D; Ciapponi A; Takwoingi Y; Deeks JJ; Emperador D; Leeflang MMG; Van den Bruel A;
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014780. PubMed ID: 39679851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light-chain amyloidosis with concomitant symptomatic myeloma (CRAB-SLiM features): clinical characteristics, cytogenetic abnormalities, and outcomes.
    Yu C; Li J; Xu T; Wang W; Yang Y; Zhou C; Wang P; Liu P
    BMC Cancer; 2024 Nov; 24(1):1449. PubMed ID: 39587494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of health care costs and resource utilization for commonly used proteasome inhibitor-immunomodulatory drug-based triplet regimens for the management of patients with relapsed/refractory multiple myeloma in the United States.
    Sanchez L; Chari A; Cheng M; Cherepanov D; DerSarkissian M; Huang F; Stull DM; Dabora J; Young M; Noga SJ; Pi S; Zhang M; Banatwala A; Duh MS; Ailawadhi S
    J Manag Care Spec Pharm; 2023 Nov; 29(11):1205-1218. PubMed ID: 37776124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.